James D. Green, Ph.D., D.A.B.T.

Dr. Green is Senior Vice President of Preclinical and Clinical Development Sciences at Biogen Idec, Inc., in the USA.  Formerly, he was Senior Director, Product Development and Safety Evaluation at Genentech, Inc., and before that Director of Toxicological Research in the Pharmaceutical Division of the Ciba-Geigy Corporation.  Dr. Green is a diplomat of the American Board of Toxicology and is a former member and past Chairman of the U.S. Pharmaceutical Research and Manufacturers Association’s Drug Safety Subsection Steering Committee.  He is currently Chairman of Biotechnology Industry Association’s nonclinical safety evaluation expert committee, BioSafe.  He is also a member of a number of professional societies, including the American Chemical Society, American College of Toxicology, American Society of Toxicology and the American Society of Toxicologic Pathologists.  Dr. Green received his BA in biology from the University of Rochester and MS and Ph.D. in environmental toxicology from New York University.  He has presented and published extensively in the area of safety evaluation of biotechnology products.